MEDICAL DEVICE RECALLS IN CANADA FROM 2005 TO 2015

Anna R Gagliardi1, Julie Takata1, Ariel Ducey2

  • 1Division of Support Systems and Outcomes,Toronto General Hospital Research Institute.

Abstract

Insights

Over 7,000 medical device recalls occurred in Canada between 2005 and 2015, with most involving intermediate-risk devices. A small percentage of recalls were high-risk, indicating potential serious harm.

Area of Science:

  • Medical Device Safety
  • Public Health Surveillance
  • Epidemiology

Background:

  • Medical devices are essential in healthcare, yet data on their market epidemiology, including recall rates, is limited.
  • Understanding medical device recalls is crucial for patient safety and regulatory oversight.

Purpose of the Study:

  • To investigate the epidemiology of medical device recalls in Canada from 2005 to 2015.
  • To analyze recall risks based on device classification and hazard priority.

Main Methods:

  • Utilized Health Canada data spanning a 10-year period (2005-2015).
  • Analyzed medical device recalls by risk class (I-IV) and recall hazard priority (Type I-III).

Main Results:

  • A total of 7,226 medical device recalls were recorded.
  • The majority of recalls involved intermediate-risk devices (Class II and III).
  • Approximately 5.0% of recalled devices were classified as Type I, indicating a high probability of serious adverse health consequences or death.

Conclusions:

  • Hundreds of medical device recalls occur annually in Canada.
  • Further research is necessary to understand the characteristics of these recalls and consumer engagement with recall information.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.8K